E de Clercq - JoVE Visualize

Showing results (241-250 of 1,143) with videos related to

Pageof 115

Sort By:

Bioorganic & Medicinal Chemistry Letters|May 1, 2001

Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPAC Ballatore, C McGuigan, E De Clercq, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1993

Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivoJ Neyts, F Stals, C Bruggeman, et al.

The Biochemical Journal|January 1, 1984

Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNAJ Balzarini, E De Clercq, D Ayusawa, et al.

Nucleic Acids Symposium Series|January 1, 1983

Inhibition of terminal deoxynucleotidyltransferase by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphateK Ono, H Nakane, L Colla, et al.

FEBS Letters|July 23, 1984

Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitorsJ Balzarini, E de Clercq, D Ayusawa, et al.

Biochimica Et Biophysica Acta|September 29, 1979

Mechanism of binding of mouse interferon to controlled pore glassI A Braude, V G Edy, E de Clercq

Journal of Medical Virology|May 1, 1992

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency miceJ Neyts, J Balzarini, L Naesens, et al.

Journal of Medicinal Chemistry|April 1, 1991

Synthesis and antiretrovirus properties of 5'-isocyano-5'-deoxythymidine, 5'-isocyano-2',5'-dideoxyuridine, 3'-azido-5'-isocyano-3',5'-dideoxythymidine, and 3'-azido-5'-isocyano-2',3',5'-trideoxyuridineJ Hiebl, E Zbiral, J Balzarini, et al.

Virology|July 1, 1992

Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysisD Schols, R Pauwels, J Desmyter, et al.

Molecular Pharmacology|May 1, 1990

Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replicationE De Clercq, R Bernaerts, A Merta, et al.

Pageof 115

Showing results (241-250 of 1,143) with videos related to

Sort By:

Pageof 115

Bioorganic & Medicinal Chemistry Letters|May 1, 2001

Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPAC Ballatore, C McGuigan, E De Clercq, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1993

Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivoJ Neyts, F Stals, C Bruggeman, et al.

The Biochemical Journal|January 1, 1984

Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNAJ Balzarini, E De Clercq, D Ayusawa, et al.

Nucleic Acids Symposium Series|January 1, 1983

Inhibition of terminal deoxynucleotidyltransferase by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphateK Ono, H Nakane, L Colla, et al.

FEBS Letters|July 23, 1984

Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitorsJ Balzarini, E de Clercq, D Ayusawa, et al.

Biochimica Et Biophysica Acta|September 29, 1979

Mechanism of binding of mouse interferon to controlled pore glassI A Braude, V G Edy, E de Clercq

Journal of Medical Virology|May 1, 1992

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency miceJ Neyts, J Balzarini, L Naesens, et al.

Journal of Medicinal Chemistry|April 1, 1991

Synthesis and antiretrovirus properties of 5'-isocyano-5'-deoxythymidine, 5'-isocyano-2',5'-dideoxyuridine, 3'-azido-5'-isocyano-3',5'-dideoxythymidine, and 3'-azido-5'-isocyano-2',3',5'-trideoxyuridineJ Hiebl, E Zbiral, J Balzarini, et al.

Virology|July 1, 1992

Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysisD Schols, R Pauwels, J Desmyter, et al.

Molecular Pharmacology|May 1, 1990

Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replicationE De Clercq, R Bernaerts, A Merta, et al.

Pageof 115